The Journal of Experimental Medicine
Track the topics, authors and articles important to you
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 10 January 2005 doi:10.1084/jem.20041502
Rockefeller University Press, 0022-1007 $8.00
JEM, Volume 201, Number 2, 279-289
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3169K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perfettini, J.-L.
Right arrow Articles by Kroemer, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perfettini, J.-L.
Right arrow Articles by Kroemer, G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
*Genetics Home Reference
Hazardous Substances DB
*L-SERINE
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

ARTICLE

Essential role of p53 phosphorylation by p38 MAPK in apoptosis induction by the HIV-1 envelope

Jean-Luc Perfettini1, Maria Castedo1, Roberta Nardacci2, Fabiola Ciccosanti2, Patricia Boya1, Thomas Roumier1, Nathanael Larochette1, Mauro Piacentini2,3, and Guido Kroemer1

1 Centre National Recherche Scientifique-UMR8125, Institut Gustave Roussy, F-94805 Villejuif, France
2 National Institute for Infectious Diseases "Lazzaro Spallanzani, " 00149 Rome, Italy
3 Department of Biology, University of Rome "Tor Vergata," 00173, Rome, Italy

CORRESPONDENCE Dr. Guido Kroemer: kroemer{at}igr.fr

The proapoptotic activity of the transcription factor p53 critically depends on the phosphorylation of serine 46 (p53S46P). Here, we show that syncytia containing p53S46P could be detected in lymph node biopsies from human immunodeficiency virus (HIV)-1 carriers, in the brain of patients with HIV-1–associated dementia and in cocultures of HeLa expressing the HIV-1 envelope glycoprotein complex (Env) with HeLa cells expressing CD4. In this latter model, cell death was the result of a sequential process involving cell fusion, nuclear fusion (karyogamy), phosphorylation of serine 15 (p53S15P), later on serine 46 (p53S46P), and transcription of p53 target genes. Cytoplasmic p38 mitogen-activated protein kinase (MAPK) was found to undergo an activating phosphorylation (p38T180/Y182P [p38 with phosphorylated threonine 180 and tyrosine 182]) before karyogamy and to translocate into karyogamic nuclei. p38T180/Y182P colocalized and coimmunoprecipitated with p53S46P. Recombinant p38 phosphorylated recombinant p53 on serine 46 in vitro. Inhibition of p38 MAPK by pharmacological inhibitors, dominant-negative p38, or small interfering RNA, suppressed p53S46P (but not p53S15P), the expression of p53-inducible genes, the conformational activation of proapoptotic Bax and Bak, the release of cytochrome c from mitochondria, and consequent apoptosis. p38T180/Y182P was also detected in HIV-1–induced syncytia, in vivo, in patients' lymph nodes and brains. Dominant-negative MKK3 or MKK6 inhibited syncytial activation of p38, p53S46P, and apoptosis. Altogether, these findings indicate that p38 MAPK-mediated p53 phosphorylation constitutes a critical step of Env-induced apoptosis.


Abbreviations used: ATF-2T271P, ATF-2 with phosphorylated tyrosine 271; Cdk1, cyclin-dependent kinase-1; DN, dominant-negative; Env, envelope glycoprotein complex; GFP, green fluorescent plasmid; HIP, homeodomain-interacting protein; MKK3/6 S189/207P, MKK3 with phosphorylated serine 189 and/or MKK6 with phosphorylated serine 207; mTOR, mammalian target of rapamycin; p38T180/Y182P, p38 with phosphorylated threonine 180 and tyrosine 182; p53S15P, p53 with phosphorylated serine 15; p53S46P, p53 with phosphorylated serine 46; PEG, polyethylene glycol.

M. Piacentini and G. Kroemer are senior authors on this paper.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS